What confirmatory test should be performed for syphilis if the Venereal Disease Research Laboratory (VDRL) test is positive but a quantitative titre is not available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Confirmatory Test for VDRL-Positive Syphilis

Perform a treponemal test—specifically FTA-ABS (fluorescent treponemal antibody absorbed) or TP-PA (T. pallidum particle agglutination)—to confirm any positive VDRL result, regardless of whether a quantitative titer is available.

Why Confirmation is Essential

The VDRL is a nontreponemal test that can produce false-positive results in 0.14-0.24% of the general population 1, 2. Using only one type of serologic test is insufficient for diagnosis because false-positive nontreponemal test results may occur secondary to various medical conditions 3, 4. Multiple CDC guidelines consistently emphasize that both nontreponemal (VDRL/RPR) and treponemal tests must be used together for presumptive diagnosis 3, 4.

The Standard Diagnostic Algorithm

The traditional syphilis testing approach involves:

  • Screening: Nontreponemal test (VDRL or RPR)
  • Confirmation: Treponemal test (FTA-ABS, TP-PA, or MHA-TP)

A positive VDRL or RPR test must be confirmed with an FTA-ABS test 5. This two-test approach distinguishes true syphilis infection from biological false-positive (BFP) reactions.

Specific Treponemal Tests for Confirmation

The CDC guidelines list acceptable treponemal confirmatory tests 3, 4:

  • FTA-ABS (fluorescent treponemal antibody absorbed)
  • TP-PA (T. pallidum particle agglutination)
  • MHA-TP (microhemagglutination assay for antibody to T. pallidum)

Any of these tests can confirm a positive VDRL result. The choice depends on laboratory availability, though FTA-ABS and TP-PA are most commonly used in current practice 4, 6.

Why the Titer Doesn't Matter for Confirmation

Regardless of VDRL titer—even at low titers like 1:2 or 1:4—treponemal confirmation is mandatory. Research demonstrates that TPHA (a treponemal test) positivity was 86.8% in sera with VDRL titers less than 1:8, meaning many true syphilis cases present with low titers 7. Studies show that among VDRL-reactive samples, BFP reactions can comprise 11-26% of positive results, with even higher rates (24%) in antenatal populations 2.

Common Causes of False-Positive VDRL

Be aware that BFP reactions occur more frequently in:

  • Pregnant women (higher BFP rate in this population) 7, 2
  • HIV-infected persons (10-fold higher BFP rate at 2.1% vs 0.24%) 1
  • Autoimmune diseases (especially systemic lupus erythematosus) 8
  • Older adults (>60 years: 0.34% vs <60 years: 0.25%) 1
  • Injection drug users 8
  • Other infections (malaria, leprosy, hepatitis B and C) 8

Critical Clinical Caveat

Among all VDRL-positive samples, approximately 26% are biological false positives 1. In antenatal populations, this rises to nearly one-third of reactive samples 2. This high false-positive rate makes treponemal confirmation absolutely essential before diagnosing syphilis and initiating treatment.

The ratio of true positives to false positives is approximately 8:1 in general populations, but this varies significantly by patient demographics 2. Never rely on VDRL alone—always confirm with a treponemal test 3, 4, 7, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.